Contents for you

Patients get antsy amid protracted price bargaining for Spinraza, Evrysdi

Hanmi begins clinical trial of dual antibody immunotherapy BH3120

Genome&Company aims to license out 2 anti-cancer candidates by 2023

[Column] Why do cancer patients have chemo nausea and vomiting?

HK inno.N's NSCLC drug picked for national drug development project

ATsens, Huinno vie for piece of global ECG patch monitoring market

Lunit to disclose AI-powered tertiary lymphoid structure analysis at World Conference on Lung Cancer

Hospitals to check patients’ eligibility for remote care from next month

JW Shinyak to resume marketing of SK bioscience’s flu vaccine

Celltrion to absorb Celltrion Healthcare in strategic merger

[Reporter's Notebook] Why MFDS should raise the ‘user fee’

JW Pharmaceutical advances phase 3 study of gout drug in Taiwan, marking 1st foreign IND milestone

FDA OKs GC Cell’s US affiliate for phase 1 study of NK cell therapy to treat lupus nephritis

SGLT-2 inhibitor diabetes drug proves effective in alleviating NASH symptoms: study

'Safety regulations used in airplanes, now essential for hospital industry'

Japan approved 1st locally-developed mRNA Covid-19 vaccine. What about Korea?

Hanmi reorganizes returned pipelines after confirming their ‘potential’

Lotte Biologics, Roche Diagnostics shake hands to advance CDMO business